The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Wednesday broker round-up

Wed, 29th Jul 2020 13:29

(Sharecast News) - Sanne: RBC Capital Markets reiterates sector performer with a target price of 600.0p.

Reckitt Benckiser: Berenberg reiterates buy with a target price of 9,000.0p.

RELX: Berenberg reiterates hold with a target price of 1,800.0p.

Petropavlovsk: Canaccord reiterates buy with a target price of 40.0p.

Tyman: Canaccord reiterates hold with a target price of 206.0p.

RB: Deutsche Bank reiterates buy with a target price of 8,400.0p.

AstraZeneca: Barclays reiterates overweight with a target price of 9,300.0p.

Greencore Group: Barclays reiterates underweight with a target price of 120.0p.

Greggs: Peel Hunt reiterates sell with a target price of 1,200.0p.

Rathbone Brothers: Peel Hunt reiterates buy with a target price of 2,595.0p.

PureTech: Liberum reiterates buy with a target price of 490.0p.

Fresnillo: JP Morgan reiterates neutral with a target price of 800.0p.

Moneysupermarket: Credit Suisse reiterates neutral with a target price of 325.0p.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.